Migraine Prophylaxis

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2022-07-20
Clinical Trial Update: A Multicenter, Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of Subcutaneous AGX-201 for Migraine Prophylaxis [Phase 2]
Phase 2 randomized trial evaluating subcutaneous AGX-201 for migraine prophylaxis; current status not specified.